These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 38375578)

  • 1. Transforming native exosomes to engineered drug vehicles: A smart solution to modern cancer theranostics.
    Sahoo RK; Tripathi SK; Biswal S; Panda M; Mathapati SS; Biswal BK
    Biotechnol J; 2024 Jan; 19(2):e2300370. PubMed ID: 38375578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosome-Based Smart Drug Delivery Tool for Cancer Theranostics.
    Kar R; Dhar R; Mukherjee S; Nag S; Gorai S; Mukerjee N; Mukherjee D; Vatsa R; Chandrakanth Jadhav M; Ghosh A; Devi A; Krishnan A; Thorat ND
    ACS Biomater Sci Eng; 2023 Feb; 9(2):577-594. PubMed ID: 36621949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell membrane, stem cell-derived exosomes and hybrid stem cell camouflaged nanoparticles: A promising biomimetic nanoplatforms for cancer theranostics.
    Khosravi N; Pishavar E; Baradaran B; Oroojalian F; Mokhtarzadeh A
    J Control Release; 2022 Aug; 348():706-722. PubMed ID: 35732250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomes: A Cutting-Edge Theranostics Tool for Oral Cancer.
    Kalele K; Nyahatkar S; Mirgh D; Muthuswamy R; Adhikari MD; Anand K
    ACS Appl Bio Mater; 2024 Mar; 7(3):1400-1415. PubMed ID: 38394624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aptamer-guided extracellular vesicle theranostics in oncology.
    Tran PH; Xiang D; Nguyen TN; Tran TT; Chen Q; Yin W; Zhang Y; Kong L; Duan A; Chen K; Sun M; Li Y; Hou Y; Zhu Y; Ma Y; Jiang G; Duan W
    Theranostics; 2020; 10(9):3849-3866. PubMed ID: 32226524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered Exosomes as Theranostic Platforms for Cancer Treatment.
    Yang X; Xie X; Liu S; Ma W; Zheng Z; Wei H; Yu CY
    ACS Biomater Sci Eng; 2023 Oct; 9(10):5479-5503. PubMed ID: 37695590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered Exosomes for Drug Delivery in Cancer Therapy: A Promising Approach and Application.
    Fu P; Yin S; Cheng H; Xu W; Jiang J
    Curr Drug Deliv; 2024; 21(6):817-827. PubMed ID: 37438904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications.
    Rahbarghazi R; Jabbari N; Sani NA; Asghari R; Salimi L; Kalashani SA; Feghhi M; Etemadi T; Akbariazar E; Mahmoudi M; Rezaie J
    Cell Commun Signal; 2019 Jul; 17(1):73. PubMed ID: 31291956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.
    Kim H; Kim EH; Kwak G; Chi SG; Kim SH; Yang Y
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomes as Therapeutic Vehicles for Cancer.
    Lim W; Kim HS
    Tissue Eng Regen Med; 2019 Jun; 16(3):213-223. PubMed ID: 31205851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive review of engineered exosomes from the preparation strategy to therapeutic applications.
    Fan X; Zhang Y; Liu W; Shao M; Gong Y; Wang T; Xue S; Nian R
    Biomater Sci; 2024 Jul; 12(14):3500-3521. PubMed ID: 38828621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update in the applications of exosomes in cancer theranostics: from research to clinical trials.
    Shahraki K; Boroumand PG; Lotfi H; Radnia F; Shahriari H; Sargazi S; Mortazavi SS; Shirvaliloo M; Shirvalilou S; Sheervalilou R
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):8087-8116. PubMed ID: 37010586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-free synthesis of connexin 43-integrated exosome-mimetic nanoparticles for siRNA delivery.
    Lu M; Zhao X; Xing H; Liu H; Lang L; Yang T; Xun Z; Wang D; Ding P
    Acta Biomater; 2019 Sep; 96():517-536. PubMed ID: 31284098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomes: Diagnostic Biomarkers and Therapeutic Delivery Vehicles for Cancer.
    Jiang L; Gu Y; Du Y; Liu J
    Mol Pharm; 2019 Aug; 16(8):3333-3349. PubMed ID: 31241965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomes as drug delivery systems: A brief overview and progress update.
    Patil SM; Sawant SS; Kunda NK
    Eur J Pharm Biopharm; 2020 Sep; 154():259-269. PubMed ID: 32717385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomes as smart drug delivery vehicles for cancer immunotherapy.
    Zhang H; Wang S; Sun M; Cui Y; Xing J; Teng L; Xi Z; Yang Z
    Front Immunol; 2022; 13():1093607. PubMed ID: 36733388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosome-based delivery strategies for tumor therapy: an update on modification, loading, and clinical application.
    Yang Q; Li S; Ou H; Zhang Y; Zhu G; Li S; Lei L
    J Nanobiotechnology; 2024 Jan; 22(1):41. PubMed ID: 38281957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aptamer-Exosomes for Tumor Theranostics.
    Yi K; Rong Y; Huang L; Tang X; Zhang Q; Wang W; Wu J; Wang F
    ACS Sens; 2021 Apr; 6(4):1418-1429. PubMed ID: 33755415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encapsulation and assessment of therapeutic cargo in engineered exosomes: a systematic review.
    Chen Z; Xiong M; Tian J; Song D; Duan S; Zhang L
    J Nanobiotechnology; 2024 Jan; 22(1):18. PubMed ID: 38172932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosome-based nanocarriers as bio-inspired and versatile vehicles for drug delivery: recent advances and challenges.
    Zhang M; Zang X; Wang M; Li Z; Qiao M; Hu H; Chen D
    J Mater Chem B; 2019 Apr; 7(15):2421-2433. PubMed ID: 32255119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.